Personal profile
Research interests
Dr. Prasad serves as Director of Clinical Theranostics in the Division of Nuclear Medicine, Mallinckrodt Institiute of Radiology. His Research interests include Clinical theranostics, Translational theranostics and Clinical trial design of Phase 1-Phase 3 trials in theranostics.
Education activities and interests
Prior to joining Washington University in St Louis, I have been involved in development of curriculum for
- Neuroendocrine neoplasm specialist's curriculum for European Neuroendocrine Tumor Society / UEMS
- Radiomolecular Precision Oncology Curriculum for the International Center of Precision Oncology Academy
- Perceptorships for European Society for Medical Oncology
- Involved in training and mentoring of PhD students, MD PhD students, fellows.
- Development of graduate medical school student's curriculum.
Available to Mentor:
- PhD Students
- Postdocs
- Residents and Fellows
Fingerprint
Dive into the research topics where Vikas Prasad is active. These topic labels come from the works of this person and are generated automatically. Together they form a unique fingerprint. Contact the Profiles team with questions.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Advances in SPECT and PET Reconstruction for Theranostics
Enninful, K., Ahmed, F., Girod, B., Laforest, R., Thorek, D. L. J., Prasad, V. & Jha, A. K., Jan 2026, In: PET Clinics. 21, 1, p. 55-71 17 p.Research output: Contribution to journal › Article › peer-review
-
Clinical Dosimetry Models and Pathway to Integration in Routine Nuclear Medicine Practice
Akerele, M., Singh, B., Mikell, J., Kaur, K., Prasad, V. & Laforest, R., Mar 2026, In: Clinical nuclear medicine. 51, 3, p. e203-e218Research output: Contribution to journal › Editorial
-
[68Ga] labelled Exendin for radioguided surgery of intrapancreatic insulin producing lesions in patients with congenital hyperinsulinism
Kühnen, P., Prasad, S., Rothe, K., Huang, K., Hauptmann, K., Boss, M., Beindorff, N., Lankes, E., Warmann, S. W., Schneider, M., Taghavi, P. A., Lechner, L., Lange, C., Furth, C., Gotthardt, M., Brenner, W., Blankenstein, O. & Prasad, V., Dec 2025, In: EJNMMI Research. 15, 1, 107.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Scopus citations -
Advances in Molecular Imaging for Neuroendocrine Neoplasms
Girod, B. & Prasad, V., Jun 2025, In: Cancers. 17, 12, 2013.Research output: Contribution to journal › Review article › peer-review
Open Access -
Challenges in developing response evaluation criteria for peptide receptor radionuclide therapy: A consensus report from the European Neuroendocrine Tumor Society Advisory Board Meeting 2022 and the ENETS Theranostics Task Force
Prasad, V., Koumarianou, A., Denecke, T., Sundin, A., Deroose, C. M., Pavel, M., Christ, E., Lamarca, A., Caplin, M., Castaño, J. P., Dromain, C., Falconi, M., Grozinsky-Glasberg, S., Hofland, J., Knigge, U. P., Kos-Kudla, B., Krishna, B. A., Reed, N. S., Scarpa, A. & Srirajaskanthan, R. & 4 others, , Feb 2025, In: Journal of Neuroendocrinology. 37, 2, e13479.Research output: Contribution to journal › Article › peer-review
Open Access10 Link opens in a new tab Scopus citations